Women's Health

New Test Could Predict Risk of Breast Cancer Recurrence

Beneficial for both doctor and patient

Beneficial for both doctor and patient

As Dr. David Gunthry says, they have successfully developed a new blood test the can simultaneously copy number alterations that are integral in driving the growth of breast cancer and detect somatic mutations. The researchers how that this test can help both doctors and patients choose the best treatment at the most helpful time by analyzing blood plasma and measuring it for genetic changes that are cancer-specific, such as the oestrogen receptor gene and the HER2 gene mutations.